CTC
Dashboard
Interface
Vaccinations
Add Vaccination
All Vaccinations
Packages
Add Package
All Packages
Blogs
Add Blog
All Blogs
Section Content
Add Section Item
All Section Items
Contacts
All Contacts
Settings
Home Page Settings
Contact Us Settings
About Page Settings
Profile Settings
Pages
Add Page
All Pages
3+
Alerts Center
December 12, 2019
A new monthly report is ready to download!
December 7, 2019
$290.29 has been deposited into your account!
December 2, 2019
Spending Alert: We've noticed unusually high spending for your account.
Show All Alerts
7
Message Center
Hi there! I am wondering if you can help me with a problem I've been having.
Emily Fowler · 58m
I have the photos that you ordered last month, how would you like them sent to you?
Jae Chun · 1d
Last month's report looks great, I am very happy with the progress so far, keep up the good work!
Morgan Alvarez · 2d
Am I a good boy? The reason I ask is because someone told me that people say this to all dogs, even if they aren't good...
Chicken the Dog · 2w
Read More Messages
Admin
Profile
Settings
Activity Log
Logout
Edit Vaccination
Name
Description
The chikungunya vaccine (Vimkunya) protects against the chikungunya virus, a mosquito-borne illness that causes fever and severe joint pain. Recommended by UK TravelHealthPro for travellers to affected tropical and subtropical regions.
Price
Currency
Dose
Age From
Age To
Vaccination Link
Additional Details
Timing
Effectiveness
Duration
Additional Notes
Timing Note
Chikungunya vaccination is not part of the routine UK immunisation schedule. It is recommended for travellers at higher risk of exposure in endemic areas.
Effectiveness Note
Research trials have shown that a single dose produces a strong immune response in most individuals. Protective antibodies typically develop within a few weeks, significantly reducing the risk of severe illness and long-lasting joint problems caused by chikungunya.
Duration Note
The vaccine can remain effective for several months to a number of years, depending on the vaccine formulation. In the future, booster doses may be advised if long-term protection is found to decrease.
Risk Information
High Risk Areas (one per line)
Sub-Saharan Africa Indian subcontinent (India, Pakistan, Bangladesh, Sri Lanka) South East Asia (Thailand, Indonesia, Philippines, Malaysia) Caribbean islands Central and South America Indian Ocean islands (Mauritius, Réunion, Seychelles)
Traveller Risk Factors (one per line)
Travel to tropical or subtropical regions where chikungunya is present Long-stay or frequent travellers Stays in rural areas or during outbreaks Outdoor activities with high mosquito exposure Underlying medical conditions or older adults at higher risk of severe disease
Protection Information
Protection Title
Protection Description
The vaccine works as it makes the immune system produce antibodies against the chikungunya virus. It is this reaction of the immune system that is utilized to prevent infection or reduce the intensity of the disease. Protection reduces the chances of chronic pain in the joints as a result of chikungunya. The use of vaccination does not substitute mosquito-bite prevention.
Media
Image
Drag & drop an image here or click to select
Update
Back
Ready to Leave?
×
Select "Logout" below if you are ready to end your current session.
